CovidResearchTrials by Shray Alag

CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)

Hydroxychloroquine + PlaceboWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation

Correlated Drug Terms (3)

Name (Synonyms) Correlation
drug318 Ciclesonide Inhalation Aerosol Wiki 1.00
drug1019 Placebo + Placebo Wiki 1.00
drug594 Hydroxychloroquine + Azithromycin Wiki 0.71

Correlated MeSH Terms (7)

Name (Synonyms) Correlation
D011024 Pneumonia, Viral NIH 0.14
D012128 Respiratory Distress Syndrome, Adult NIH 0.10
D003141 Communicable Diseases NIH 0.10
D011014 Pneumonia NIH 0.07
D007239 Infection NIH 0.07
D045169 Severe Acute Respiratory Syndrome NIH 0.06
D018352 Coronavirus Infections NIH 0.05

Correlated HPO Terms (1)

Name (Synonyms) Correlation
HP:0002090 Pneumonia HPO 0.07

There is one clinical trial.

Clinical Trials

1 Qatar Prospective RCT Of Therapy Eliminating Covid Transmission

Q-PROTECT is a placebo controlled randomized trial (RCT) to ascertain the efficacy of hydroxychloroquine (HC) alone or, in combination with azithromycin (AZ), in reducing viral load in patients with COVID 19.

NCT04349592 Covid19 Drug: Hydroxychloroquine + Azithromycin Drug: Hydroxychloroquine + Placebo Other: Placebo + Placebo

Primary Outcomes

Description: Days

Measure: Proportion of virologically cured (no virus detected) cases at day 6

Time: Day 6

Secondary Outcomes

Description: Days

Measure: The dichotomous virologic shedding endpoint as assessed at two weeks after study entry

Time: 2 weeks

Description: Days

Measure: Quantitative viral load (assessed with each virology testing set)

Time: Day 1 to 21

No related HPO nodes (Using clinical trials)